過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)重組蛋白
Recombinant Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha (PPARgC1a)
LEM6; PGC-1(alpha); PGC-1v; PGC1; PGC1A; PPARGC1; Ligand effect modulator 6
- 編號RPH337Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞核
- 預測分子量25.2kDa
- 實際分子量25kDa(差異分析請參閱說明書)
- 片段與標簽Ser573~Asn767 with N-terminal His Tag
- 緩沖液成份100mMNaHCO3, 500mMNaCl, pH8.3, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點9.6
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1056 ¥ 2640 ¥ 5280 ¥ 15840 ¥ 39600
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
SDS-PAGE圖
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPH337Hu02 | 過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPH337Hu01 | 過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAH337Hu02 | 過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)多克隆抗體 | WB; IHC; ICC; IP. |
| PAH337Hu01 | 過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)多克隆抗體 | WB; IHC; ICC; IP. |
| MAH337Hu21 | 過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)單克隆抗體 | WB; IHC; ICC; IP. |
| SEH337Hu | 過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMH337Hu | 過氧化物酶體增殖物激活受體γ輔激活因子1α(PPARgC1a)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Coronary Artery Disease | Impaired myocardium energetics associated with the risk for new-onset atrial fibrillation after isolated coronary artery bypass graft surgery [Pubmed: 24463787] |
| Molecular and cellular biochemistry | Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension [Pubmed: 23099843] |
| Diabetes. | Inorganic nitrate promotes the browning of white adipose tissue through the nitrate-nitrite-nitric oxide pathway [Pubmed:25249574] |
| Psychoneuroendocrinology | Maternal stress predicts altered biogenesis and the profile of mitochondrial proteins in the frontal cortex and hippocampus of adult offspring rats [PubMed: 26143539] |
| Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | The level of circulating PGC1α in cardiovascular diseases [Article: 10.1134] |
| Neuroscience Letters | Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis [pubmed:28483651] |
| The American Journal of the Medical Sciences | Serum peroxisome proliferator-activated receptor gamma coactivator-1α related to myocardial energy expenditure in patients with chronic heart failure [Doi: 10.1016/j.amjms.2018.12.002] |
| Brain Research | The effect of antecedent-conditioning high-intensity interval training on BDNF regulation through PGC-1α pathway following cerebral ischemia [Pubmed: 31866362] |
| Food & Function | Ubiquinol supplementation modulates energy metabolism and bone turnover during high intensity exercise [Pubmed: 32797125] |
| Brown and beige adipose tissue regulate systemic metabolism to resist diet-induced obesity through metabolite signals in an inter-organ signaling axis [] | |
| CLINICAL NUTRITION | Long lasting protective EFFECTS of early L-ARGININE TREAMENT on ENDOTHELIUM in an in Vitro STUDY [33743287] |
| Nature Communications | Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis [33772024] |
留言咨詢
